These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8990447)

  • 1. Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy.
    Akkad AA; Halligan AW; Abrams K; al-Azzawi F
    Obstet Gynecol; 1997 Jan; 89(1):97-103. PubMed ID: 8990447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women.
    Cacciatore B; Paakkari I; Hasselblatt R; Nieminen MS; Toivonen J; Tikkanen MI; Ylikorkala O
    Am J Obstet Gynecol; 2001 Apr; 184(5):904-9. PubMed ID: 11303197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women.
    Vongpatanasin W; Tuncel M; Mansour Y; Arbique D; Victor RG
    Circulation; 2001 Jun; 103(24):2903-8. PubMed ID: 11413078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of transdermal estrogen therapy on some vasoactive humoral factors and 24-h ambulatory blood pressure in normotensive postmenopausal women.
    Zacharieva S; Atanassova I; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Aslanova N
    Climacteric; 2002 Sep; 5(3):293-9. PubMed ID: 12419088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy.
    Tuomikoski P; Haapalahti P; Sarna S; Ylikorkala O; Mikkola TS
    Ann Med; 2010 Jul; 42(5):334-43. PubMed ID: 20429800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J; Sumino H; Ichikawa S; Ozaki M
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of different hormone replacement therapy regimens on circadian blood pressure profile and active renin in postmenopausal women.
    Zacharieva S; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Orbetzova M; Atanassova I
    Gynecol Endocrinol; 2002 Dec; 16(6):461-7. PubMed ID: 12626033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerobic training abolishes ambulatory blood pressure increase induced by estrogen therapy: a double blind randomized clinical trial.
    Cardoso CG; Rosas FC; Oneda B; Labes E; Tinucci T; Abrahão SB; da Fonseca AM; Mion D; Forjaz CL
    Maturitas; 2011 Jun; 69(2):189-94. PubMed ID: 21493022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of different types and doses of oestrogen replacement therapy on clinic and ambulatory blood pressure and the renin-angiotensin system in normotensive postmenopausal women.
    Harvey PJ; Wing LM; Savage J; Molloy D
    J Hypertens; 1999 Mar; 17(3):405-11. PubMed ID: 10100079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of estrogen replacement therapy on natriuretic peptides and blood pressure.
    Karjalainen AH; Ruskoaho H; Vuolteenaho O; Heikkinen JE; Bäckström AC; Savolainen MJ; Kesäniemi YA
    Maturitas; 2004 Mar; 47(3):201-8. PubMed ID: 15036490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of low-dose 17beta-estradiol plus dydrogesterone on 24-h ambulatory blood pressure in healthy postmenopausal women: a 1-year, randomized, prospective study.
    Kaya C; Cengiz SD; Cengiz B; Akgun G
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():62-7. PubMed ID: 17943541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women.
    Seely EW; Walsh BW; Gerhard MD; Williams GH
    Hypertension; 1999 May; 33(5):1190-4. PubMed ID: 10334810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
    Circulation; 2002 Oct; 106(14):1771-6. PubMed ID: 12356628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term transdermal hormone replacement therapy on the renin-angiotensin- aldosterone system, plasma bradykinin levels and blood pressure in normotensive postmenopausal women.
    Ichikawa A; Sumino H; Ogawa T; Ichikawa S; Nitta K
    Geriatr Gerontol Int; 2008 Dec; 8(4):259-64. PubMed ID: 19149837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study.
    Helle SI; Omsjø IH; Hughes SC; Botta L; Hüls G; Holly JM; Lønning PE
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):727-32. PubMed ID: 9039339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term effects of low-dose 17beta-estradiol and dydrogesterone hormone replacement therapy on 24-h ambulatory blood pressure in hypertensive postmenopausal women: a 1-year randomized, prospective study.
    Kaya C; Dinçer Cengiz S; Cengiz B; Akgün G
    Climacteric; 2006 Dec; 9(6):437-45. PubMed ID: 17085376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis.
    Eilertsen AL; Høibraaten E; Os I; Andersen TO; Sandvik L; Sandset PM
    Maturitas; 2005 Oct; 52(2):111-8. PubMed ID: 16186073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.